Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.

GEP-NETs MEN1 circulating miRNAs miRNAs non-invasive biomarkers parathyroid glands personalized medicine pituitary gland

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Oct 2020
Historique:
received: 24 09 2020
revised: 12 10 2020
accepted: 12 10 2020
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 26 2 2021
Statut: epublish

Résumé

Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited tumor syndrome, characterized by the development of multiple neuroendocrine tumors (NETs) in a single patient. Major manifestations include primary hyperparathyroidism, gastro-entero-pancreatic neuroendocrine tumors, and pituitary adenomas. In addition to these main NETs, various combinations of more than 20 endocrine and non-endocrine tumors have been described in MEN1 patients. Despite advances in diagnostic techniques and treatment options, which are generally similar to those of sporadic tumors, patients with MEN1 have a poor life expectancy, and the need for targeted therapies is strongly felt. MEN1 is caused by germline heterozygous inactivating mutations of the

Identifiants

pubmed: 33066578
pii: ijms21207592
doi: 10.3390/ijms21207592
pmc: PMC7589704
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Circulating MicroRNA 0
MEN1 protein, human 0
Proto-Oncogene Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Biochem Genet. 2017 Jun;55(3):253-267
pubmed: 28315020
BMC Cancer. 2019 Jun 13;19(1):575
pubmed: 31196127
Orphanet J Rare Dis. 2006 Oct 02;1:38
pubmed: 17014705
Front Physiol. 2014 Feb 17;5:39
pubmed: 24596559
Front Horm Res. 2013;41:1-15
pubmed: 23652667
RNA Biol. 2012 Sep;9(9):1147-54
pubmed: 22951590
PLoS One. 2012;7(6):e39767
pubmed: 22761894
Biosci Biotechnol Biochem. 2019 Jun;83(6):1035-1044
pubmed: 30973065
Int J Mol Sci. 2018 Sep 15;19(9):
pubmed: 30223590
Cell Cycle. 2015;14(16):2590-7
pubmed: 26125663
PLoS One. 2012;7(3):e30679
pubmed: 22427800
World J Gastroenterol. 2018 Feb 7;24(5):573-582
pubmed: 29434446
Bioessays. 2016 Apr;38(4):367-78
pubmed: 26934338
Med Sci Monit. 2017 Mar 13;23:1277-1285
pubmed: 28288092
Nat Struct Mol Biol. 2015 Jan;22(1):20-8
pubmed: 25565029
Clin Chem. 2010 Nov;56(11):1733-41
pubmed: 20847327
Cancer Lett. 2015 Jan 28;356(2 Pt B):568-78
pubmed: 25305447
Int J Mol Sci. 2016 Aug 12;17(8):
pubmed: 27529237
PLoS One. 2015 May 05;10(5):e0125553
pubmed: 25942502
Clin Chem. 2008 Mar;54(3):482-90
pubmed: 18218722
Front Genet. 2019 Jul 18;10:626
pubmed: 31379918
J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011
pubmed: 22723327
Int J Endocrinol. 2018 May 6;2018:2342860
pubmed: 29853878
Endocr Pathol. 2019 Jun;30(2):128-133
pubmed: 30767148
Medicine (Baltimore). 2015 Dec;94(50):e2224
pubmed: 26683934
Nat Cell Biol. 2011 Apr;13(4):423-33
pubmed: 21423178
Endocr Relat Cancer. 2019 Jan 1;26(1):47-57
pubmed: 30021866
Pituitary. 2017 Aug;20(4):450-463
pubmed: 28432562
Oncol Rep. 2018 May;39(5):2342-2350
pubmed: 29565463
Hum Mutat. 2008 Jan;29(1):22-32
pubmed: 17879353
Endocr Relat Cancer. 2010 Feb 18;17(1):135-46
pubmed: 19926710
Eur J Endocrinol. 2018 Oct 01;179(4):219-228
pubmed: 30299890
Biol Reprod. 2012 Mar 19;86(3):71
pubmed: 22116803
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):2-15
pubmed: 23933118
Am J Pathol. 2017 Mar;187(3):570-580
pubmed: 28087162
F1000 Med Rep. 2010 Feb 24;2:
pubmed: 20948872
PLoS One. 2010 Oct 29;5(10):e13735
pubmed: 21060830
Neurosurgery. 2014 Aug;75(2):181-9; discussion 188-9
pubmed: 24739366
Cell Physiol Biochem. 2017;44(2):792-803
pubmed: 29176323
Trends Genet. 2015 Nov;31(11):613-626
pubmed: 26453491
Am J Pathol. 2011 Oct;179(4):2120-30
pubmed: 21871428
Am J Physiol Endocrinol Metab. 2014 Jul 1;307(1):E84-92
pubmed: 24824656
Endocr Relat Cancer. 2018 Jul;25(7):761-771
pubmed: 29724878
Clin Epigenetics. 2019 Feb 11;11(1):25
pubmed: 30744689
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Trends Cell Biol. 2012 Mar;22(3):125-32
pubmed: 22260888
Br J Haematol. 2008 May;141(5):672-5
pubmed: 18318758
Front Endocrinol (Lausanne). 2019 Jun 11;10:339
pubmed: 31263451
Eur Rev Med Pharmacol Sci. 2016 Jul;20(13):2842-52
pubmed: 27424984
Int J Mol Sci. 2019 Sep 05;20(18):
pubmed: 31491899
Neuroendocrinology. 2018;106(4):312-317
pubmed: 28848144
Oncotarget. 2017 Aug 18;8(44):77028-77040
pubmed: 29100367
F1000Res. 2017 Jan 24;6:
pubmed: 28184288
World J Gastrointest Oncol. 2017 Sep 15;9(9):341-353
pubmed: 28979716
Horm Metab Res. 2017 Jul;49(7):550-557
pubmed: 28472828
Eur Heart J. 2013 Nov;34(44):3451-7
pubmed: 23386708
Oncotarget. 2018 Jun 19;9(47):28379-28390
pubmed: 29983867
RNA Biol. 2018 Mar 4;15(3):338-352
pubmed: 29570036
Pituitary. 2011 Jun;14(2):112-24
pubmed: 21063788
Mol Cell Endocrinol. 2016 Sep 5;432:83-95
pubmed: 26525415
QJM. 1996 Sep;89(9):653-69
pubmed: 8917740
Int J Endocrinol. 2019 Jul 17;2019:8516858
pubmed: 31391849
Nat Rev Genet. 2011 Feb;12(2):99-110
pubmed: 21245828
J Biomed Sci. 2013 Oct 04;20:72
pubmed: 24093444
Mol Neurobiol. 2013 Apr;47(2):726-39
pubmed: 23150170
Nat Commun. 2014 Feb 28;5:3292
pubmed: 24576947
Virchows Arch. 2017 Sep;471(3):401-411
pubmed: 28597079
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
Int J Biol Sci. 2012;8(1):118-23
pubmed: 22211110
Diagnostics (Basel). 2020 Apr 16;10(4):
pubmed: 32316225
Sci Rep. 2018 Aug 13;8(1):12016
pubmed: 30104706
Med Sci Monit. 2016 Dec 24;22:5101-5108
pubmed: 28012286
Avicenna J Med Biotechnol. 2010 Oct;2(4):161-79
pubmed: 23407304
Thromb Haemost. 2014 Jul 3;112(1):128-36
pubmed: 24573468
Ann Intern Med. 1998 Sep 15;129(6):484-94
pubmed: 9735087
Mol Biosyst. 2016 May 24;12(6):1922-8
pubmed: 27098433
Endocr J. 2019 Aug 29;66(8):709-722
pubmed: 31061247
Oncol Rep. 2019 Aug;42(2):533-548
pubmed: 31173251
Endocrine. 2019 Sep;65(3):646-655
pubmed: 31165412
Oncotarget. 2016 Jul 19;7(29):45462-45478
pubmed: 27323780
Tumour Biol. 2016 Oct;37(10):13469-13477
pubmed: 27465551
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
pubmed: 18663219
Genet Mol Res. 2016 Mar 24;15(1):
pubmed: 27050992
Turk Neurosurg. 2017 Sep 26;:
pubmed: 29091246
Am J Transl Res. 2017 Apr 15;9(4):1743-1753
pubmed: 28469779
PLoS One. 2011;6(6):e20769
pubmed: 21698099
Eur Rev Med Pharmacol Sci. 2015 Feb;19(4):624-9
pubmed: 25753880
J Clin Endocrinol Metab. 2019 May 21;:
pubmed: 31112271
Adv Nutr. 2011 Nov;2(6):472-85
pubmed: 22332090
Int J Mol Sci. 2017 Feb 01;18(2):
pubmed: 28157158
J Endocrinol. 2018 Sep 1;:
pubmed: 30389902
Neuroendocrinology. 2018;107(1):73-90
pubmed: 29566385
Oncol Rep. 2018 Mar;39(3):1235-1244
pubmed: 29399695
J Alzheimers Dis. 2008 May;14(1):27-41
pubmed: 18525125
Endocrine. 2018 May;60(2):246-254
pubmed: 29453660
Trends Biochem Sci. 2012 Nov;37(11):460-5
pubmed: 22944280

Auteurs

Simone Donati (S)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Simone Ciuffi (S)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Francesca Marini (F)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Gaia Palmini (G)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Francesca Miglietta (F)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Cinzia Aurilia (C)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Maria Luisa Brandi (ML)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Unit of Bone and Mineral Diseases, University Hospital of Florence, Largo Palagi 1, 50139 Florence, Italy.
Fondazione Italiana Ricerca sulle Malattie dell'Osso (FIRMO Onlus), 50141 Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH